Quarterly report · Q1
4323.TEDINET S100RO43
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥122m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥261m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥62m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥63m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥18.3bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥17.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥138m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥405m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥266m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥5.05 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.5 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.26 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.2% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥628m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥825m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥807m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥19m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥104m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥961m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥960m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥407,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥750m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥513m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥688m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥682m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥11m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥67,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥132m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥774m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 470
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent liabilities | Prior1YearInstant | 1893578000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1878960000 | JPY |
| Liabilities | Prior1YearInstant | 6597556000 | JPY |
| Liabilities | CurrentQuarterInstant | 7793623000 | JPY |
| Capital stock | Prior1YearInstant | 1535409000 | JPY |
| Capital stock | CurrentQuarterInstant | 1535409000 | JPY |
| Capital surplus | Prior1YearInstant | 1702732000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1702732000 | JPY |
| Retained earnings | Prior1YearInstant | 7389420000 | JPY |
| Retained earnings | CurrentQuarterInstant | 7054094000 | JPY |
| Treasury stock | Prior1YearInstant | -175703000 | JPY |
| Treasury stock | CurrentQuarterInstant | -175861000 | JPY |
| Shareholders equity | Prior1YearInstant | 10451859000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 10116375000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 137114000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 155587000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 119184000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 129239000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 60618000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 57496000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 316917000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 342323000 | JPY |
| Non controlling interests | Prior1YearInstant | 47463000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 47840000 | JPY |
| Net assets | Prior1YearInstant | 10816240000 | JPY |
| Net assets | CurrentQuarterInstant | 10506539000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 17413797000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 18300162000 | JPY |
| Net sales | Prior1YTDDuration | 5119276000 | JPY |
| Net sales | CurrentYTDDuration | 5640211000 | JPY |
| Cost of sales | Prior1YTDDuration | 3826933000 | JPY |
| Cost of sales | CurrentYTDDuration | 4280524000 | JPY |
| Gross profit | Prior1YTDDuration | 1292342000 | JPY |
| Gross profit | CurrentYTDDuration | 1359686000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1030962000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1237668000 | JPY |
| Operating income | Prior1YTDDuration | 261380000 | JPY |
| Operating income | CurrentYTDDuration | 122018000 | JPY |
| Interest income noi | Prior1YTDDuration | 3656000 | JPY |
| Interest income noi | CurrentYTDDuration | 8230000 | JPY |
| Dividends income noi | Prior1YTDDuration | 4401000 | JPY |
| Dividends income noi | CurrentYTDDuration | 4172000 | JPY |
| Rent income noi | Prior1YTDDuration | 604000 | JPY |
| Rent income noi | CurrentYTDDuration | 791000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 13683000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 7078000 | JPY |
| Insurance income noi | Prior1YTDDuration | － | JPY |
| Insurance income noi | CurrentYTDDuration | 14700000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 4231000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 2398000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |